- Advertisement -
- Advertisement -

Related

Rhenman & Partners Boosts Biopharma Expertise

Latest Report

- Advertisement -

Stockholm (HedgeNordic) – Rhenman & Partners is expanding its five-person investment team with the hiring of Amennai Beyeen as a biopharma analyst. He joins from global healthcare company Novartis.

“We are very happy to welcome Amennai to Rhenman & Partners,” says Henrik Rhenman, co-founder and CIO at Rhenman & Partners. “Amennai’s strong background and competence from the world of research, and his experience of pharmaceutical companies where he has been able to closely follow processes from idea to finished product make him a very good addition to our investment team.”

“We are very happy to welcome Amennai to Rhenman & Partners.”

Amennai Beyeen has worked for about 12 years at Novartis, focusing on the development and launch of new drugs. He also holds a doctorate in neuroimmunology from Karolinska Institutet in Stockholm. Beyeen will join the five-person investment team running the healthcare-focused equity hedge fund Rhenman Healthcare Equity L/S. He will have a particular focus on biopharma companies and the development of new drugs and treatments.

“It is very exciting to start at Rhenman & Partners,” Amennai Beyeen comments on joining the Swedish healthcare-focused asset manager. “I am extremely impressed by the team’s deep knowledge of the healthcare sector as well as the fund’s versatile investment process, which is reflected in its strong results over the years,” he continues. “I look forward to joining this competent team and contributing with my experience from the life science sector.”

Rhenman & Partners Asset Management has been running its long-biased equity hedge fund with an exclusive focus on healthcare since mid-2009, delivering an annualized return of 17.3 percent through November 2022. The fund’s main share class (IC1 EUR) edged down 1.6 percent in the first 11 months of this year. Rhenman Healthcare Equity L/S oversees €923 million in assets under management.

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Ridge Capital Strengthens Client-Facing Team with London Hire

Credit hedge fund manager Ridge Capital has strengthened its client-facing team with the hiring of Pierre Giannini as Business Development and Investor Relations Europe....

Tidan to Launch Confluence, Its Integrated Multi-Strategy Fund

Stockholm-based Tidan Capital is preparing to launch Confluence, a new multi-strategy vehicle that brings the boutique’s internally managed strategies under one umbrella. The fund,...

State Pension Fund of Finland Sees Strong Hedge Fund Gains

The first half of 2025 brought a complex market backdrop shaped by shifting macroeconomic trends, tariffs, geopolitical uncertainty, and volatile investor sentiment. Although returns...

Espiria Rolls Out Long-Only Fund Led by Staffan Östlin

After more than a decade of picking stocks on both the long and short side, veteran fund manager Staffan Östlin is now running a...

The “Magic of Three”: Protean Select Turns Milestone into Major Allocation

Reaching the three-year mark is a key milestone and often a turning point for any emerging hedge fund. For Protean Select, the opportunistic equity...

Twelve Years On, Nordkinn Expands with Two PMs and Advisor

Twelve years after its inception, Nordkinn Asset Management is entering a new growth phase, expanding its investment team with the appointments of Arian Kalantari...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.